Correction: The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab

Detalles Bibliográficos
Autores principales: Magnes, T., Melchardt, T., Hufnagl, C., Weiss, L., Mittermair, C., Neureiter, D., Klieser, E., Rinnerthaler, G., Roesch, S., Gaggl, A., Greil, R., Egle, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096332/
https://www.ncbi.nlm.nih.gov/pubmed/30659276
http://dx.doi.org/10.1038/s41397-019-0073-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096332/
https://www.ncbi.nlm.nih.gov/pubmed/30659276
http://dx.doi.org/10.1038/s41397-019-0073-5

Ejemplares similares